These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2897307)

  • 1. Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    Radhakishun FS; Horn AS; Van Ree JM
    Eur J Pharmacol; 1988 Feb; 147(1):137-40. PubMed ID: 2897307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.
    Radhakishun FS; Westerink BH; Stoof JC; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):127-36. PubMed ID: 7919942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
    Radhakishun FS; Stoof JC; Mulder AH; Versteeg DH; van Ree JM
    Brain Res; 1987 Nov; 426(2):235-42. PubMed ID: 2961411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM; Caffé AR; Wolterink G
    Neuropharmacology; 1982 Nov; 21(11):1111-7. PubMed ID: 6184640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin.
    Radhakishun FS; Westerink BH; van Ree JM
    Neurosci Lett; 1988 Jul; 89(3):328-34. PubMed ID: 2901702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute haloperidol attenuates the hypomotility induced with 7-hydroxy-DPAT.
    Lynch MR; Ormsby JL
    Neuroreport; 1997 Feb; 8(3):611-5. PubMed ID: 9106733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C; Cummins R; Gnoffo Z; Kew JN
    Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a chromanamine analogue (DP-6OH-3CA) of the selective presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Vermue NA; Dijkstra D; Horn AS
    J Pharm Pharmacol; 1988 Aug; 40(8):574-7. PubMed ID: 2907015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine.
    Van Ree JM; Innemee H; Louwerens JW; Kahn RS; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1095-101. PubMed ID: 6184639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C; De Vries JB; Dijkstra D; Horn AS
    Eur J Pharmacol; 1981 Apr; 70(4):541-50. PubMed ID: 6113149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the (+)-and (-)-enantiomers of sulpiride on ADTN-induced hyperactivity in the rat [proceedings].
    Andrews CD; Woodruff GN
    Br J Pharmacol; 1978 Nov; 64(3):434P. PubMed ID: 719284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.